Bank of America vs. Goldman Sachs: Which Financial Stock Is a Better Buy in 2026?

For fiscal 2025, Bank of America reported revenue of about $191.6 billion, down 0.5% year over year, and net income of $30.5 billion; Goldman Sachs reported revenue of $125.1 billion, down 1.4%, and net income of $17.2 billion. The article favors Goldman Sachs for its stronger share performance, while noting Bank of America's lower forward P/E (11.5 vs. 13.0) and P/S ratio (1.8 vs. 2.1). Risks cited include a $1.2 billion Bank of America regulatory charge in 2026 and a $500 million Goldman Sachs shareholder-litigation settlement.

Analysis

The article’s ranking is not a clean valuation call: the cited multiples and cash-flow ratios need verification, and current ratio, debt/equity, and free cash flow are poor stand-alone comparators for large banks with different balance-sheet models. Do not use the reported negative GS free cash flow as evidence of funding stress without reconciling regulatory-capital and balance-sheet movements.

The real distinction is exposure. BAC is more levered to deposit pricing, loan growth, credit costs and the yield curve; GS is more levered to underwriting, deal activity and trading conditions. A rebound in capital markets can lift GS earnings faster, but a risk-off shock can reverse that advantage abruptly. GS’s consumer-credit exits may reduce strategic distraction, though execution and transition costs remain; the Apple partnership change is not, by itself, evidence of material impact to either company.

Near term, settlements and legal charges can distort reported results; distinguish one-offs from underlying expense trends. Over 1–3 months, watch GS investment-banking backlog/conversion and markets revenue, and BAC net interest income, deposit costs, criticized commercial real-estate exposures and credit provisions. Over 6–18 months, the key question is whether GS can convert its institutional focus into durable returns without relying on unusually strong markets, versus whether BAC can improve spread income without credit deterioration.

Contrarian angle: recent relative performance may have already priced in GS’s cyclical recovery, while the article’s “value” framing for BAC may overlook rate and credit sensitivity. The signal is not strong enough to justify an outright directional call absent verified estimates and current prices.

Key Decisions for Investors

• Prefer a conditional relative-value watch: consider long GS / short BAC only if upcoming results confirm improving GS underwriting or markets revenue while BAC net interest income or credit quality disappoints. Keep the position modest; upside is cyclical operating leverage, while the main risk is a market slowdown that hurts GS more sharply.
• Do not initiate solely on the cited forward P/E or free-cash-flow figures. Reconcile company filings and comparable earnings definitions first, including BAC deposit costs and GS balance-sheet cash-flow movements.
• Falsify the relative thesis if GS deal activity and backlog weaken or markets revenue falls, or if BAC shows sustained net interest income improvement alongside stable credit provisions. Reassess after the next earnings releases rather than chasing historical share-price performance.
• Monitor BAC commercial real-estate credit metrics and any material regulatory developments; monitor GS’s consumer-business exit costs and litigation-related charges separately from recurring operating performance.